Key Market Indicator:
F&G: 57
25.745,80 NASDAQ · 48.853,99 DOW · 6.933,75 S&P · 5.337,00 Gold · 69,37 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
© ActuNews
23.01.2026
ISIN: BE0974487192

Oxurion NV
OXUR

LISTED

EURONEXT
Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIUM – January 23, 2026 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on January 22, 2026, from Atlas Special Oppo...
Themefolio
Profiler
Peergroup
© ActuNews
23.01.2026
ISIN: BE0974487192

Oxurion NV
OXUR

LISTED

EURONEXT
Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
News Preview
Leuven, BELGIË – 23 januari 2026 – 18u00 CET Oxurion NV (Euronext Brussel: OXUR), een bedrijf met hoofdkantoor in Leuven, België, heeft vandaag aangekondigd dat het, in overeenstemming met de Belgische transparantiewetgeving1, de volgende transparantiekennisgeving heeft ontvangen: Oxurion ontving een transparantiekennisgeving...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: SE0002190926

Karolinska Development AB
KDEV

LISTED

STO
Karolinska Development AB receives additional guarantee commitments in ongoing rights issue
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar

USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© ACCESS Newswire
23.01.2026
ISIN: CA98980M1095

Zomedica Corp.
ZOMDF

LISTED

OTC
Zomedica Expands its TRUVIEW(R) Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity
News Preview
AI-enabled hematology and cytology analysis improves diagnostic speed, consistency, and workflow efficiency for veterinary clinics ANN ARBOR, MI / ACCESS Newswire / January 23, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company providing innovative point-of-care diagnostic and therapeutic...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© PR Newswire
23.01.2026
ISIN: GB00BN455J50

Worldwide Healthcare Trust PLC
WWH

LISTED

LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC LEI: 5493003YBCY4W1IMJU04 NET ASSET VALUE The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© BusinessWire
23.01.2026
ISIN: US30048L3024

Evofem Biosciences, Inc
EVFM

LISTED

OTC
Evofem CEO Saundra Pelletier Calls for a “Ground-Up Reset” of Women’s Health at Fierce JPM Week 2026
News Preview
Women's health innovator Evofem Biosciences, Inc. ("Evofem") (OTCID: EVFM) announced today that CEO Saundra Pelletier’s fiery keynote address at Fierce JPM Week 2026 is now available for on-demand viewing. “If men suffered from endometriosis, it would be solved by now,” said Pelletier. “Historically, clinical trials excluded women because our ho...
Themefolio
Profiler
Peergroup
© Newsfile
23.01.2026
ISIN: CA14161Y2006

Cardiol Therapeutics Inc
CRDL

LISTED

TSX
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
News Preview
Toronto, Ontario--(Newsfile Corp. - January 23, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced that it has closed its previously announced private pla...
Themefolio
Profiler
Peergroup
© Newsfile
23.01.2026
ISIN: CA88410L1022

Thiogenesis Therapeutics, Corp.
TTI

LISTED

TSX
Thiogenesis Presents Phase 2 (EU) MELAS Data at Mitocon 2026
News Preview
Highlighting Optimized Once-Daily Weight-Based Dosing and Clinically Meaningful Fatigue ImprovementSan Diego, California--(Newsfile Corp. - January 23, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing next-generation thiol-based prodrugs for rare m...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
23.01.2026
ISIN: US31573L1052

FibroBiologics Inc.
FBLG

LISTED

NASDAQ
DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
News Preview
ATLANTIC CITY, NJ / ACCESS Newswire / January 23, 2026 / DealFlow Events today announced the growing list of companies scheduled to present and participate in one-on-one meetings with investors and analysts at the DealFlow Discovery Conference, taking place January 28-29, 2026, at the Borgata Hotel Casino & Spa in Atlantic City.More than 100 pu...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: US46120E6023

Intuitive Surgical Inc
ISRG

LISTED

NASDAQ
20 Million Patients Benefit from da Vinci Surgery Globally
News Preview
Achievement reflects the dedication of surgeons and care teams worldwide to improving patient outcomes through use of Intuitive’s minimally invasive technologies Achievement reflects the dedication of surgeons and care teams worldwide to improving patient outcomes through use of Intuitive’s minimally invasive technologies...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
23.01.2026
ISIN: US76135L1017

Revelation Biosciences, Inc.
REVB

LISTED

NASDAQ
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds
News Preview
SAN DIEGO, CA / ACCESS Newswire / January 23, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation, announced today the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase...
Themefolio
Profiler
Peergroup
© PR Newswire
23.01.2026
ISIN: US1266501006

CVS Health Corp
CVS

LISTED

NYSE
CVS Health supports communities as major winter storm approaches
News Preview
Pharmacy patients encouraged to pick up prescriptions before conditions deteriorateWOONSOCKET, R.I., Jan. 23, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) is actively preparing for the major winter storm expected to impact much of the country over the next few days. The company's priority is the health and safety of its customers, members and coll...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
23.01.2026
ISIN: US09058V1035

BioCryst Pharmaceuticals Inc
BCRX

LISTED

NASDAQ
BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema 
News Preview
RESEARCH TRIANGLE PARK, N.C., Jan. 23, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has completed its acquisition of Astria Therapeutics, Inc., initially announced on October 14, 2025. The transaction strengthens its position as a leader in hereditary angioedema (HAE) and enhances the company’s lo...
Themefolio
Profiler
Peergroup
© BusinessWire
23.01.2026
ISIN: US00846U1016

Agilent Technologies Inc
A

LISTED

NYSE
Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System
News Preview
Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, available for sale in key European markets. The launch reflects Agilent’s continued investment in digital pathology, expanding its portfolio to meet the growing demand for high-throughput solutions...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: CA59633Q1037

Middlefield Healthcare Dividend ETF
MHCD

LISTED

TSX
Middlefield Healthcare Dividend ETF Distributions
News Preview
TORONTO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Middlefield Healthcare Dividend ETF (TSX: MHCD) (the “Fund”) is pleased to announce that distributions for the first quarter of 2026 will be payable to unitholders of Middlefield Healthcare Dividend ETF as follows:...
Themefolio
Profiler
Peergroup
© BusinessWire
23.01.2026
ISIN: US03152W1099

Amicus Therapeutics Inc
FOLD

LISTED

NASDAQ
FOLD Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Amicus Therapeutics, Inc. is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Amicus Therapeutics, Inc. (NASDAQ: FOLD) to BioMarin Pharmaceutical Inc. for $14.50 per share is fair to Amicus shareholders. Halper Sadeh encourages Amicus shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Z...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.01.2026
ISIN: DE0006044001

Maternus Kliniken AG
MAK

LISTED

XETR
Beabsichtigte Standortschließungen
News Preview
Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014 Beabsichtigte Standortschließungen Berlin, den 23.01.2026 – Der Vorstand der MATERNUS-Kliniken-Aktiengesellschaft (ISIN DE0006044001, WKN 604400) hat mit Zustimmung des Aufsichtsrats beschlossen, die folgenden Betriebe verschiedener Konzerngesellschaften im......
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: US5288723027

Lexicon Pharmaceuticals Inc
LXRX

LISTED

NASDAQ
Lexicon Pharmaceuticals to Ring the Nasdaq Closing Bell on January 27, 2026 to Celebrate 30th Anniversary
News Preview
THE WOODLANDS, Texas, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will ring the Nasdaq Stock Market Closing Bell on Tuesday, January 27, 2026....
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: US1940145022

Enovis Corp
ENOV

LISTED

NYSE
Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th
News Preview
Dallas, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2025 financial results on Thursday, February 26th, 2026 at 8:30 a.m. Eastern Time and issue a...
Themefolio
Profiler
Peergroup
© BusinessWire
23.01.2026
ISIN: CA41755F1071

Harvest Healthcare Leaders Income ETF
HHL

LISTED

TSX
Harvest ETFs Announces January 2026 Distributions
News Preview
Harvest Portfolios Group Inc. (“Harvest”) announces the following monthly distributions for Harvest ETFs in the following table for the month ending January 31, 2026. The distributions will be paid on or about February 6, 2026 to unitholders of record on January 30, 2026 with an ex-dividend date of January 30, 2026. Harvest ETF Ticker...
Themefolio
Profiler
Peergroup
© BusinessWire
23.01.2026
ISIN: CA08934P1080

Big Pharma Split Corp.
PRM

LISTED

TSX
Harvest Declares Big Pharma Split Corp. January 2026 Distribution
News Preview
Harvest Portfolios Group Inc. (“Harvest”) declares the monthly cash distribution payable for Big Pharma Split Corp. of $0.1031 for each class A share (PRM:TSX) for the month ending January 31, 2026. The distribution is payable February 6, 2026 to class A shareholders of record at the close of business January 30, 2026. For additional information...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: US0048901096

Acrivon Therapeutics Inc
ACRV

LISTED

NASDAQ
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress
News Preview
Globally recognized key opinion leader Panagiotis (Panos) Konstantinopoulos, M.D., Ph.D., Dana-Farber Cancer Institute, will highlight company’s recent interim clinical data from the ongoing, registrational-intent Phase 2b study of ACR-368 in subjects with endometrial cancer Globally recognized key opinion leader Panagiotis (Panos) Konstantinopoulo...
Themefolio
Profiler
Peergroup
© PR Newswire
23.01.2026
ISIN: IE00BTN1Y115

Medtronic PLC
MDT

LISTED

NYSE
Affera™ momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE first cases for Sphere-360™ PFA catheter to treat paroxysmal atrial fibrillation
News Preview
First-of-its-kind, rotation-free single-shot PFA catheter supported by strong safety and efficacy data adds to the groundbreaking Affera family of technologies in EuropeSuccessful completion of first cases at multiple sites kicks off Horizon 360 IDE pivotal trial in the United StatesGALWAY, Ireland, Jan. 23, 2026 /PRNewswire/ -- Medtronic plc (NYS...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: IL0011806523

Cannibble Food-Tech Ltd
PLCN

LISTED

CSE
Cannibble Food-Tech Ltd. Announces Establishment of Robotics and AI Division and Partnership to Explore Service Robotics Deployment
News Preview
ROSH HAAYIN, Israel, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Cannibble Food-Tech Ltd. (CSE: PLCN) (“Cannibble” or the “Company”) today announced the establishment of a Robotics and Artificial Intelligence Division for the Food and Hospitality Industry and the execution of a partnership agreement with AIBotics Inc. (OTC: AIBT) (“AIBotics”), a developer...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: US67577C1053

Ocugen Inc
OCGN

LISTED

NASDAQ
Ocugen, Inc. Announces Closing of $22.5 Million Underwritten Registered Direct Offering of Common Stock
News Preview
MALVERN, Pa., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Nasdaq: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing of its previously announced underwritten registered direct offering of 15,000,000 shares of its common stock at an offering price of $1.50 per share of common stock fo...
Themefolio
Profiler
Peergroup
© BusinessWire
23.01.2026
ISIN: CA1380357048

Canopy Growth Corp
CGC

LISTED

NASDAQ
Canopy Growth to Report Third Quarter Fiscal 2026 Financial Results on February 6, 2026
News Preview
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the third quarter fiscal year 2026 ended December 31, 2025 before financial markets open on February 6, 2026. Following the release of its third quarter fiscal year 2026 financial results, Canopy Growth will host an audio we...
Themefolio
Profiler
Peergroup
© BusinessWire
23.01.2026
ISIN: US45256X1037

Immunitybio Inc
IBRX

LISTED

NASDAQ
ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients Receiving ANKTIVA® Plus CAR-NK, Chemo-Free Therapy
News Preview
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company developing cytokine and cellular immunotherapies designed to restore immune competence, today announced updated Phase 2 clinical results from QUILT 3.078 (NCT06061809), evaluating a chemotherapy-free combination immunotherapy regimen in patients with second-line recurrent o...
Themefolio
Profiler
Peergroup
© PR Newswire
23.01.2026
ISIN: US0758871091

Becton Dickinson and Co
BDX

LISTED

NYSE
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation
News Preview
Newest version of BD® Research Cloud features an AI-powered tool for automated panel design to improve quality, efficiency and usability of scientific results across research areasFRANKLIN LAKES, N.J., Jan. 23, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the glob...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: US79957L1008

Sanara Medtech Inc
SMTI

LISTED

NASDAQ
Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance
News Preview
FORT WORTH, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara MedTech,” “Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today repo...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: US0017441017

AMN Healthcare Services Inc
AMN

LISTED

NYSE
AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026
News Preview
DALLAS, Jan. 23, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its fourth quarter and full year 2025 financial results and first quarter 2026 outlook on Thursday, February 19, 2026, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news releas...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: US09073N3008

Streamex Exchange Corp.
STEX

LISTED

NASDAQ
Streamex Corp. (NASDAQ: STEX) Announces Issuance of Prepayment Notice for Previously Announced Convertible Debenture Financing & Notice of Termination for Standby Equity Purchase Agreement
News Preview
WINTER PARK, Fla., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a leader in institutional-grade tokenization of commodity assets, today announced that it has delivered an optional prepayment notice to the holder of its Secured Convertible Debentures, YA II PN, LTD., a Cayman Islands exempt limited...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: GG00BD3FV870

Okyo Pharma Limited
OKYO

LISTED

LSE
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
News Preview
LONDON and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has authorized a single-p...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: US28617K1016

Eledon Pharmaceuticals, Inc.
ELDN

LISTED

NASDAQ
Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium
News Preview
Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at ASTS...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: US37953J1079

Selectis Health, Inc.
GBCS

LISTED

OTC
Selectis Health Completes Sale of Sparta and Warrenton Health & Rehabilitation Facilities in Georgia
News Preview
- Sparta and Warrenton Nursing Facilities and Related Property Sold for $13.18 Million - - Sparta and Warrenton Nursing Facilities and Related Property Sold for $13.18 Million -...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
23.01.2026
ISIN: US8883147055

Titan Pharmaceuticals, Inc.
TTNP

LISTED

NASDAQ
Institutional Access via Public Equities: Black Titan's Strategic Pivot
News Preview
NEW YORK, NY / ACCESS Newswire / January 23, 2026 / As the "DeFi-as-a-Service" (DaaS) narrative matures, public equity markets are witnessing a new phenomenon: the "Infrastructure Pivot." This week's primary focus is Black Titan Corp (BTTC), which has effectively repositioned itself from a legacy service provider into a regulate...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.01.2026
ISIN: CA50206C1005

LIR Life Sciences Corp.
SKNY

LISTED

CSE
Ist das die nächste Generation der Adipositas-Therapie? Ex-Vivo-Studie startet Q1 26
News Preview
EQS-Media / 23.01.2026 / 09:37 CET/CEST LIR Life Sciences Corp. (ISIN: CA50206C1005 | WKN: A41QA9), LIR oder das Unternehmen, freut sich, den Abschluss eines Studiendesigns für eine “Ex-vivo-Untersuchung” an Schweinehaut bekannt zu geben, mit der bewertet werden soll, ob neuartige transdermale Wirkstoffe die transdermale Penetration therapeuti......
Themefolio
Profiler
Peergroup
© ACCESS Newswire
23.01.2026
ISIN: BMG070252017

Altamira Therapeutics Ltd.
CYTO

LISTED

NASDAQ
Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit
News Preview
HAMILTON, BERMUDA / ACCESS Newswire / January 23, 2026 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCID:CYTOF), a company dedicated to developing and commercializing nucleic acid delivery technology for targets beyond the liver, announced today that it will be presenting at the 5th mRNA-Based Therapeutics Summit...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.01.2026
ISIN: CA50206C1005

LIR Life Sciences Corp.
SKNY

LISTED

CSE
LIR Life Sciences finalisiert Design einer Ex-vivo-Tierstudie zur Bewertung neuartiger transdermaler Wirkstoffe für den Transport größerer therapeutischer Moleküle
News Preview
LIR Life Sciences Corp. (ISIN: CA50206C1005 | WKN: A41QA9), LIR oder das Unternehmen, freut sich, den Abschluss eines Studiendesigns für eine Ex-vivo-Untersuchung an Schweinehaut bekannt zu geben, mit der bewertet werden soll, ob neuartige transdermale Wirkstoffe die transdermale Penetration therapeutischer Makromoleküle über einen breiten Molekülg......
Themefolio
Profiler
Peergroup
© ACCESS Newswire
23.01.2026
ISIN: CA58471K2020

Medicus Pharma Ltd.
MDCX

LISTED

TSX
Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony
News Preview
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 23, 2026 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, CEO Dr Raza Bokhari joined Steve Darlin...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.01.2026
ISIN: CH0038389992

BB Biotech AG
BION

LISTED

SIX
Vorläufige Jahresergebnisse 2025 und Dividendenvorschlag
News Preview
Medienmitteilung vom 23. Januar 2026BB Biotech: Vorläufige Jahresergebnisse 2025 und Dividendenvorschlag BB Biotech AG gibt für 2025 die folgenden vorläufigen und ungeprüften Finanzergebnisse bekannt: Gesamtjahr 2025: Die Aktie von BB Biotech erzielte eine starke Gesamtrendite von +34.2% in CHF, +37.0% in EUR und +53.7% in USD (inklusive der im M......
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: FR0005175080

Transgene SA
TNG

LISTED

EURONEXT
Transgene Further Strengthens Scientific Advisory Board with Appointments of Renowned Cancer Immunotherapy Experts Antoine Italiano and Ignacio Melero
News Preview
Transgene Further Strengthens Scientific Advisory Board with Appointments of Renowned Cancer Immunotherapy Experts Antoine Italiano and Ignacio Melero...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: DK0015998017

Bavarian Nordic A/S
BAVA

LISTED

CPH
Bavarian Nordic Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil
News Preview
Bavarian Nordic has signed a distribution agreement with Eurofarma for its chikungunya vaccine in Brazil with potential to expand to rest of Latin America...
Themefolio
Profiler
Peergroup
© EQS Newswire
23.01.2026
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments publiziert Quartalsbericht per 31. Dezember 2025 mit Kennzahlen für die ersten neun Monate des Geschäftsjahrs 2025/2026
News Preview
Quartalsgewinn von CHF 191 Millionen erhöht den Gewinn für die ersten neun Monate des Geschäftsjahrs 2025/2026 auf insgesamt CHF 286 Millionen Positive Dynamik im privaten und im börsenkotierten Portfolio Der NAV steigt 18% in der 9-Monatsperiode, der Aktienkurs überproportional fast 30%; ein verbleibender Diskont von knapp 20% signalisiert weite......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.01.2026
ISIN: CH0012627250

HBM Healthcare Investments AG
HBMN

LISTED

SIX
HBM Healthcare Investments publishes Quarterly Report as at 31 December 2025 with key figures for the first nine months of the 2025/2026 financial year
News Preview
Quarterly profit of CHF 191 million brings the profit for the first nine months of the 2025/2026 financial year to a total of CHF 286 million Positive momentum in private and public portfolios Net asset value up 18% in the nine-month period, share price increases disproportionately by almost 30%; remaining discount of......
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: FR0000120578

Sanofi SA
SAN

LISTED

EURONEXT
Press Release: Sanofi's amlitelimab confirms its potential in atopic dermatitis
News Preview
Sanofi's amlitelimab confirms its potential in atopic dermatitis...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2026
ISIN: US09073N3008

Streamex Exchange Corp.
STEX

LISTED

NASDAQ
Streamex Corp. (NASDAQ: STEX) Announces Pricing of $35 Million Public Offering
News Preview
WINTER PARK, Fla., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a leader in institutional-grade tokenization of real-world assets and commodity-backed stablecoins, including GLDY, today announced the pricing of its previously announced underwritten public offering of 11,666,667 shares of common st...
Themefolio
Profiler
Peergroup
© Newsfile
22.01.2026
ISIN: CA25244H1055

DiagnosTear Technologies Inc.
DTR

LISTED

CSE
DiagnosTear Signs Letter of Intent to Advance Commercial Expansion of TeaRx(TM) in India
News Preview
Vancouver, British Columbia--(Newsfile Corp. - January 22, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), an innovator in point-of-care ocular diagnostics, today announced the signing of a Letter of Intent (LOI) with Renovate Biologicals Pvt. Ltd. ("Renovate"), a Hyderabad-based distribution company a...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.01.2026
ISIN: CA7729241066

Rocket Doctor AI Inc
AIDR

LISTED

CSE
ROCKET DOCTOR AI INC. ANNOUNCES CLOSING OF LISTED ISSUER FINANCING EXEMPTION (LIFE) PRIVATE PLACEMENT OF UNITS
News Preview
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.01.2026
ISIN: US09073N3008

Streamex Exchange Corp.
STEX

LISTED

NASDAQ
Streamex Corp. (NASDAQ: STEX) Announces Proposed Public Offering
News Preview
WINTER PARK, Fla., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a leader in institutional-grade tokenization of real-world assets and commodity-backed stablecoins, including GLDY, today announced its intention to offer shares of common stock through an underwritten public offering. All of the shar...
Themefolio
Profiler
Peergroup
© PR Newswire
22.01.2026
ISIN: US4327053090

Tharimmune Inc
THAR

LISTED

NASDAQ
Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering
News Preview
NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ: THAR), the first publicly traded company to leverage Canton Coin to support the Canton Network's ability to digitize traditional financial markets, today announced the closing of its previously announced underwritten registered direct offering which included the issuance of 1,800,00...
Themefolio
Profiler
Peergroup
© PR Newswire
22.01.2026
ISIN: US88025U1097

10X Genomics Inc
TXG

LISTED

NASDAQ
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
News Preview
PLEASANTON, Calif., Jan. 22, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and full year ended December 31, 2025 after market close on Thursday, February 12, 2026. The company will host a public conference call and live webcast f...
Themefolio
Profiler
Peergroup
© BusinessWire
22.01.2026
ISIN: US00857U1079

agilon health inc
AGL

LISTED

NYSE
agilon health Sets Date to Report Fourth Quarter and Full Year 2025 Financial Results
News Preview
agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the fourth quarter and full year 2025 after market close on Wednesday, February 25, 2026 and host a conference call at 4:30 p.m. ET to discuss the results. The conferen...
Themefolio
Profiler
Peergroup
© BusinessWire
22.01.2026
ISIN: CA00288U1066

Abcellera Biologics Inc
ABCL

LISTED

NASDAQ
AbCellera to Report Full Year 2025 Financial Results on February 24, 2026
News Preview
AbCellera (Nasdaq: ABCL) will announce its full year 2025 financial results on Tuesday, February 24, 2026, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day. A live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera’s Investor Relations websi...
Themefolio
Profiler
Peergroup
© BusinessWire
22.01.2026
ISIN: US46266C1053

IQVIA Holdings Inc
IQV

LISTED

NYSE
IQVIA Named to the Fortune® World’s Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year
News Preview
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2026 Fortune® World’s Most Admired Companies™ list. This is the fifth year in a row IQVIA has earned first place in the Health Care: Pharmacy and Other Services category, and the ninth...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.01.2026
ISIN: US92243G1085

Vaxcyte Inc
PCVX

LISTED

NASDAQ
Vaxcyte Advances Adult and Infant Programs for VAX-31, a Potential Best-in-Class, Next-Generation Pneumococcal Conjugate Vaccine
News Preview
VAX-31 Adult Indication: Vaxcyte Doses First Participants in Phase 3 Study Evaluating Concomitant Administration of VAX-31 and Seasonal Influenza Vaccine (OPUS-2) and Expects to Initiate Phase 3 Study in Adults Previously Vaccinated with Pneumococcal Vaccines (OPUS-3) in First Quarter of 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.01.2026
ISIN: US29082K1051

Embecta Corp
EMBC

LISTED

NASDAQ
embecta to Report Fiscal First Quarter Financial Results
News Preview
PARSIPPANY, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal first quarter 2026 financial results, provide an operational update, and host a...
Themefolio
Profiler
Peergroup
© BusinessWire
22.01.2026
ISIN: US4577301090

Inspire Medical Systems Inc
INSP

LISTED

NYSE
The Law Offices of Frank R. Cruz Announces Investigation of Inspire Medical Systems, Inc. (INSP) on Behalf of Investors
News Preview
The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) concerning whether the board breached its fiduciary duties to shareholders. If you are a shareholder, click HERE to participate. On August 4, 2025, Inspire disclosed that t...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.01.2026
ISIN: US46120E6023

Intuitive Surgical Inc
ISRG

LISTED

NASDAQ
Intuitive Announces Fourth Quarter Earnings
News Preview
SUNNYVALE, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.01.2026
ISIN: US5588681057

Madrigal Pharmaceuticals Inc
MDGL

LISTED

NASDAQ
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
News Preview
CONSHOHOCKEN, Pa., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on January 15, 2026 to 40 new non-executive employees as equity inducemen...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.01.2026
ISIN: US00650F1093

Adaptive Biotechnologies Corp
ADPT

LISTED

NASDAQ
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
News Preview
SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the fourth quarter and full year 2025...
Themefolio
Profiler
Peergroup

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2026 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Thursday, 29.01.2026, Calendar Week 05, 29th day of the year, 336 days remaining until EoY.